Publications by authors named "Adiwijaya"

Claim this Profile
A
A Universal Approach Using Water-Soluble Templates for Meso- and Macro-Porous Organic Polymers.
Yusuke Asakura, Steven Adiwijaya, Shunya Yoshino, Hideki Kato, Yusuke Yamauchi

Adv Sci (Weinh)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photocatalytic Performance of Bicontinuous Concentric Lamellar Silica Decorated with Titania.
Steven Adiwijaya, Nadiatus Silmi, Didi Prasetyo Benu, Fry Voni Steky, Muhammad Wildan Azzindani

Langmuir· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved method to detect arrhythmia using ensemble learning-based model in multi lead electrocardiogram (ECG).
Satria Mandala, Ardian Rizal, Adiwijaya, Siti Nurmaini, Sabilla Suci Amini

PLoS One· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ECG-based prediction algorithm for imminent malignant ventricular arrhythmias using decision tree.
Satria Mandala, Tham Cai Di, Mohd Shahrizal Sunar, Adiwijaya

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.
Lecia V Sequist, Jhanelle Elaine Gray, Wael A Harb, Ariel Lopez-Chavez, Robert C Doebele, Bambang Adiwijaya

Oncologist· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.
Pamela Munster, Ian E Krop, Patricia LoRusso, Cynthia Ma, Barry A Siegel, Bambang S Adiwijaya

Br J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.
B S Adiwijaya, J Kim, I Lang, T Csõszi, A Cubillo

Clin Pharmacol Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oil encapsulation in core-shell alginate capsules by inverse gelation. I: dripping methodology.
Evandro Martins, Denis Renard, Zenia Adiwijaya, Emre Karaoglan, Denis Poncelet

J Microencapsul· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).
Birgit Schoeberl, Art Kudla, Kristina Masson, Ashish Kalra, Michael Curley, Bambang Adiwijaya

NPJ Syst Biol Appl· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.
Joyce F Liu, Isabelle Ray-Coquard, Frederic Selle, Andrés M Poveda, David Cibula, Bambang Adiwijaya

J Clin Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model.
Michael D Curley, Gauri J Sabnis, Lucia Wille, Bambang S Adiwijaya, Gabriela Garcia

Mol Cancer Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.
Mark S Sulkowski, Kenneth E Sherman, Douglas T Dieterich, Mohammad Bsharat, Lisa Mahnke, Bambang Adiwijaya

Ann Intern Med· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials.
Tara L Kieffer, Sandra De Meyer, Doug J Bartels, James C Sullivan, Eileen Z Zhang, Bambang Adiwijaya

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.
Bambang S Adiwijaya, Tara L Kieffer, Joshua Henshaw, Karen Eisenhauer, Holly Kimko

PLoS Comput Biol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.
Bambang S Adiwijaya, Eva Herrmann, Brian Hare, Tara Kieffer, Chao Lin

PLoS Comput Biol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid decrease of wild-type hepatitis C virus on telaprevir treatment.
Bambang S Adiwijaya, Brian Hare, Paul R Caron, John Cr Randle, Avidan U Neumann

Antivir Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects.
Doug J Bartels, Yi Zhou, Eileen Z Zhang, Michelle Marcial, Randal A Byrn, Bambang S Adiwijaya

J Infect Dis· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological network design strategies: discovery through dynamic optimization.
Bambang S Adiwijaya, Paul I Barton, Bruce Tidor

Mol Biosyst· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis